Burjeel Cancer Institute Expands Oncology Services With New Centre In Al Ain
Burjeel Cancer Institute (BCI) has broadened its services by launching a new centre at Burjeel Hospital Al Ain. This move strengthens Burjeel Holdings’ dedication to offering top-tier oncology care nationwide, ensuring more patients can access advanced cancer treatments.
The launch event was graced by John Sunil, Group CEO of Burjeel Holdings, alongside notable figures from the Al Ain Traffic Police, Abu Dhabi Agriculture and Food Safety Authority, and Al Ain Civil Defense.

BCI operates from its main facility at Burjeel Medical City in Abu Dhabi. It leads in oncology treatment and research, providing innovative therapies and a comprehensive approach to patient care. The new centre at Burjeel Hospital Al Ain underscores its commitment to expanding services and addressing the community’s growing healthcare demands with integrated, world-class medical care.
The newly established centre in Al Ain delivers a complete range of oncology services. These include expert consultations, advanced diagnostic capabilities, and specialized treatments such as chemotherapy, immunotherapy, and targeted therapies. The institute also offers extensive surgical oncology services performed by top specialists using the latest medical technologies for precision and efficiency.
To enhance patient comfort and privacy, the facility includes dedicated chemotherapy suites. This creates a supportive and personalized treatment environment. The seamless integration of these services ensures that patients receive comprehensive care from diagnosis through recovery.
Professor Humaid bin Harmal Al Shamsi, Consultant Oncologist and CEO of Burjeel Cancer Institute, highlighted the importance of this expansion. "The opening of BCI in Al Ain reflects our commitment to expanding oncology services and making specialized cancer care more accessible across the UAE. Our goal is to bring high-quality, patient-centered treatment closer to those in need, ensuring that individuals in Al Ain have access to the latest advancements in cancer care without the need to travel far."
Commitment to Accessible Care
"At BCI, we prioritise a seamless patient journey from diagnosis to treatment and recovery," he said. "With a multidisciplinary approach that enhances outcomes and quality of life. To further ease access to care, we welcome patients for consultations without requiring prior appointments, reinforcing our mission to provide an integrated and patient-first experience."
With inputs from WAM